Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 5, 2021
RFA-CA-21-041 - Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
RFA-CA-21-042 - Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The National Cancer Institute (NCI) will hold a public pre-application teleconference on Tuesday, August 31, 2021, at 2:00-4:00 PM (ET) and on Friday, September 3, 2021, at 2:00-4:00 PM (ET) for the "PDAC Stromal Reprograming Consortium (PSRC)" Funding Opportunity Announcements (FOAs):
NCI staff members involved in managing this program will provide technical assistance to potential applicants by explaining the goals and objectives of this initiative and answering questions from attendees.
Potential applicants are encouraged to submit their questions or comments to [email protected] and [email protected] in advance of the teleconference.
Registration: Potential applicants interested in participating in the teleconference should send an email to Ms. Terese Trent ([email protected]) to obtain registration information no later than 5:00 PM (ET) on August 27, 2021.
Please include "NCI Technical Assistance Webinar for PSRC FOAs” in the subject line of the email.
Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-21-041 or RFA-CA-21-042.
Peter Ujhazy, MD, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5681
Email: [email protected]
Jeff Hildesheim, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6213
Email: [email protected]